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Background: Stroke and coronary heart disease share the same risk factors, and a multifactorial 
intervention after stroke may potentially result in the same reduction in cardiovascular mortality 
as seen after coronary events. We aimed to evaluate the effect on survival 7 years after a 1-year 
multifactorial risk factor intervention, and identify clinical predictors for long-term survival 
in a hospital-based cohort of patients with first-ever stroke or transient ischemic attack (TIA).
Materials and methods: We performed a secondary analysis of a randomized controlled trial 
including patients between February 2007 and July 2008 comparing an intensive risk factor 
intervention vs usual care the first year poststroke to prevent cognitive impairment. From Febru-
ary 2014 to July 2016, all patients were invited to a follow-up. For patients dying throughout the 
follow-up period, date of death was obtained from the medical record. Examination at baseline and 
1-year follow-up included extensive assessment of vascular risk factors and cognitive assessments.
Results: A total of 195 patients were randomized. Mean (SD) age was 71.6 (12.5) years, 
53.3% were male, mean (SD) body mass index (BMI) was 25.6 (4.1) kg/m². During follow-up, 
35 patients in the intervention group and 41 in the control group died.  Kaplan–Meier survival 
estimates show no significant difference in intention-to-treat (ITT) population or complete 
case (CC) population (log-rank P=0.29 vs log-rank P=0.07). In multivariable Cox proportional 
hazards regression analyses, lower age and higher BMI was independently associated with long-
term survival, adjusted HR (95% CI) 1.08 (1.05–1.11) per year and 0.91 (0.85–0.97) per kg/m².
Conclusion: In this post hoc analysis, we found no significant effect on survival after 7 years 
of a multifactorial risk factor program given during the first year after first-ever stroke or TIA. 
Higher BMI was an independent predictor for long-term survival in this cohort.
Keywords: RCT, stroke, cardiovascular risk, risk factor management, secondary prevention
Introduction
Stroke remains one of the leading causes of disability and death worldwide,1 despite 
a decrease in stroke mortality in the last decades. The substantial long-term risk for 
recurrent stroke might justify prolonged management strategies for stroke survivors.2
After a coronary event, participation in a cardiac rehabilitation program reduces 
total and cardiovascular mortality, as well as hospital readmissions.3 Successful pro-
grams involve a multifactorial risk-reduction regimen including exercise. In  contrast, 
stroke survivors have limited lifestyle support.4 Since stroke and coronary heart disease 
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share many risk factors, a multifactorial intervention after 
stroke may potentially have beneficial effects on mortality.5
In the CAST study (Cognition After Stroke), 227 patients 
with first-ever stroke or transient ischemic attack (TIA) were 
randomized to a multifactorial intervention program aimed 
to preserve cognition. At 1 year poststroke, there were no 
statistically significant differences between the groups 
on cognition, but the intervention was associated with a 
reduction in anxiety and depression.6 More patients in the 
intervention group reached the targets for blood pressure 
and lipid values.7
Long-term follow-up of intervention studies poststroke 
are important. The aim of this follow-up and post hoc analy-
sis was to evaluate the effect on survival after 7 years of the 
1-year multifactorial risk factor intervention, and to identify 
clinical predictors for long-term survival in this hospital-
based cohort of stroke survivors.
Materials and methods
Trial design and randomization
CAST was a randomized, evaluator-blinded, controlled trial 
with two parallel groups. Patients with stroke (ischemic 
stroke or intracerebral hemorrhage) or TIA were randomized 
to intensive risk factor intervention in the outpatient clinic 
or standard care in the primary healthcare service. Patients 
in the intervention group were invited to follow-up at 3 and 
6 months, for targeted and individualized multifactorial 
vascular risk factor management. Details of the intervention 
and the short-term results have previously been reported,7 
with cognition as the primary endpoint, measured by the 
trail making test A (TMT-A)8 and the 10-word test from the 
Repeatable Battery for the Assessment of Neuropsychologi-
cal Status.9 Anxiety and depression as secondary outcomes 
assessed with Hospital Anxiety and Depression Scale10 at 12 
months and has previously been reported.6,7
Participants
All patients with a first-ever stroke or TIA, without known 
cognitive impairment, defined by a score <3.7 on the Infor-
mant Questionnaire on Cognitive Decline in the Elderly 
(IQCODE),11 admitted to the stroke unit of Baerum Hospital 
between February 2007 and July 2008, were invited to par-
ticipate in the study. Patients with a life expectancy of more 
than 1 year and able to perform cognitive assessments were 
randomized following the acute phase (day 7–10). From Feb-
ruary 2014 to July 2016, surviving participants were invited 
to a follow-up. For patients who died during follow-up, the 
date of death was obtained from the patients’ medical record 
and all-cause mortality was assessed through data from the 
Norwegian Causes of Death Register. Since this is a follow-
up study, power calculation was based on the primary aim 
of the initial study.7
assessments
At baseline, recorded vascular risk factors included treated 
hypertension prestroke, hyperlipidemia (total cholesterol >5.0 
mmol/L, low-density lipoprotein [LDL]-cholesterol >3.0 
mmol/L), diabetes mellitus (an established diagnosis or 
hemoglobin A1C [HbA1c] ≥7.0%), atrial fibrillation (AF), 
current smoking, and daily alcohol intake. Patients under-
went neuroimaging with MRI or computerized tomography. 
Functional outcome was assessed with the modified Rankin 
scale (mRS).12 Neurological impairments were measured by 
the National Institute of Health Stroke Scale,13 and activities 
of daily living (ADL) were assessed using the Bartel ADL 
index14 at baseline and follow-up. Cognition was assessed 
with Mini Mental State Examination (MMSE),15 TMT-A, 
and 10-word tests at baseline, after 12 months, and at 7 years 
follow-up. The same team of physicians and study nurse were 
used during the study.
Fasting blood samples, electrocardiography, and blood 
pressure were collected at baseline and12 months follow-up. 
At the same time points, weight and height were measured 
and body mass index (BMI) calculated. Calculated BMI 
groups: 1: <18.5 kg/m2 underweight, 2: 18.5–24.9 kg/m2 
normal weight, 3: 25.0–29.9 kg/m2 overweight, and 4: >30.0 
kg/m2 obese. Self-reported smoking, alcohol use, physical 
activity, and current medication were recorded.
intervention
Patients in the intervention group were invited to the outpatient 
clinic for a consultation with a study nurse and stroke physi-
cian at 3, 6, and 12 months. The intervention was based on 
the American Heart Association (AHA) 2006 recommenda-
tions regarding secondary stroke prevention16 and included 
medical treatment and promotion of a healthy lifestyle. Risk 
factor targets were blood pressure ≤140/90 mmHg, total 
cholesterol ≤5.0 mmol/L, LDL-cholesterol ≤3.0 mmol/L, 
HbA1c≤7.0%, homocysteine ≤15 µmol/L, and BMI ≤25 
kg/m.2 The medical treatment was optimized, and patient edu-
cation was given individually regarding stroke recurrence risk, 
prognosis, rehabilitation, and how to preserve brain health. 
Tailored advice regarding lifestyle changes included regular 
moderate physical activities and possibilities for strength and 
balance training and smoking cessation courses in groups if 
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and fish, low-fat dairy products, and less sugar in combina-
tion with encouragement to avoid excessive use of alcohol.
statistical analyses
Baseline characteristics are given in mean ± SD or as number 
and percentage as appropriate. Categorical variables were 
compared with Pearson’s chi-squared test and continuous 
variables with independent Student’s t-test. The long-term 
effect of the intervention upon survival was analyzed using 
Kaplan–Meier plots and Cox proportional hazard models 
adjusting for age and BMI. Predictors of survival were 
assessed using univariable and multivariable Cox proportional 
hazards regression analyses. The assumptions of proportional 
hazards were checked by visual inspection of log minus log 
plots. Variables with P<0.1 in univariable analyses were 
included in the multivariable analysis. Finally, as an explor-
atory analysis, we used Kaplan–Meier plots and log-rank test 
to study the effect of different BMI categories on survival. 
Analyses were performed using SPSS Statistic version 23.
ethical approval and informed consent
Ethical approval for this study was obtained from the 
Regional Committee for Ethics in Medical Research and 
by the Data Protection Authorities (2013/1829). Written 
informed consent was obtained from all subjects or next of 
kind before inclusion in the study.
Results
study population and intervention
Of the 227 patients included in 2007/2008, a total of 195 patients 
were randomized. Of the 13 patients who did not complete the 
intervention, eight patients discontinued and five died during the 
first year. Mean follow-up time was 7.3 years (0–9.9), with 76 
deaths in total; 35 patients (36 %) in the intervention group and 
41 (42 %) in the control group. Thus, the intention-to-treat (ITT) 
analysis comprised 98 patients in the intervention group and 97 
in the control group, and the complete-case (CC) analysis com-
prised 85 patients in the intervention group and 97 in the control 
group. Flowchart of the study population is presented in Figure 1.
At baseline there was no significant group differences 
regarding age, BMI, stroke subtype, risk factors, or MMSE 
scores. At 12 months, significantly more patients in the inter-
vention group reached the treatment targets for systolic blood 
pressure and hyperlipidemia. Daily alcohol use and cigarette 
smoking were reduced in both the groups, but without any 
significant difference. No significant difference was seen 
regarding physical activity; mean 225±224 min/week in the 
intervention group and 192±201 min/week in the control 
group, P=0.30. At 12 months, mean BMI was significantly 
higher in the intervention group; mean 26.6±3.2 kg/m2 in the 
intervention group vs 25.7±4.5 kg/m2 in the control group, 
P=0.007. After 7 years, mean BMI was 26.8 (SD 3.8) kg/m2 in 
the intervention group and 26.7 (SD 4.0) kg/m2 in the control 
group, and ~70% of the survivors had a BMI >25 kg/m2. The 
baseline characteristics of the study population, including risk 
factor measurements after 1 year, are presented in Table 1.
intervention and long-term effect on 
mortality
Kaplan–Meier survival curves for the ITT and the CC 
population, respectively, are presented in Figure 2. Log-rank 
P-values are 0.29 (ITT) and 0.07 (CC).
Figure 1 Flowchart of the study population.
227 included
195 randomized
98 intervention 97 control
4 died
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In multivariate Cox regression analysis, adjusted for age 
and BMI, we found no significant difference between the 
intervention and the control group, neither in ITT analysis 
(HR 0.92, 95% CI 0.56–1.52) nor in CC analysis (HR 0.71, 
95% CI 0.41–1.23). Causes of death during follow-up are 
presented in Table 3. 
Predictors for long-term survival
All baseline variables shown in Table 1 were assessed using 
Cox proportional hazards regression analyses (Table 2). In the 
univariable models, higher age and higher mRS score were 
associated with higher mortality, whereas hyperlipidemia, 
higher BMI, and higher MMSE at discharge were associated 
Table 1 Baseline characteristics and risk factors at 12 months
Patients characteristics Baseline 12 months P-value
Intervention Control Intervention Control
n 98 97 85 93
Male (%) 45 (46) 59 (61) 41 (48) 55 (59)
age, years (mean [sD]) 72.6 (11.2) 70.6 (13.6) 73.6 (11.2) 71.6 (13.6)
Stroke subtype (%)
cerebral infarction 72 (74) 77 (79)
Tia 20 (20) 10 (10)
cerebral hemorrhage 6 (6) 10 (10)
Risk factors (%)
Hypertension* 60 (61) 54 (65) 26 (38) 43 (62) 0.04
Hyperlipidemia 56 (57) 53 (55) 9 (10) 22 (24) 0.04
Diabetes 8 (8) 13 (13)
cigarette smoking (present) 18 (18) 24 (25) 8 (9) 18 (19) 0.10
coronary heart disease 21 (21) 26 (27)
Atrial fibrillation 34 (35) 24 (25)
Daily alcohol use 20 (24) 17 (18) 7 (8) 13 (14) 0.36
BMi >25 60 (61) 53 (55) 58 (53) 52 (47) 0.13
BMi, kg/m2 (mean [sD]) 26.0 (3.9) 25.1 (4.4) 26.6 (3.2) 25.7 (4.5) 0.01
OCSP classification (%)
Taci 3 (3) 7 (7)
Paci 51 (52) 47 (49)
laci 31 (32) 30 (31)
POci 12 (13) 13 (13)
Topography (%)
Right hemisphere 36 (37) 38 (39)
left hemisphere 46 (47) 49 (51)
cerebellum/brainstem 16 (16) 10 (10)
Assessments (SD)
niHss day 1, mean 2.0 (2.2) 3.0 (4.1)
niHss at discharge, mean 1.0 (1.4) 1.6 (2.8)
Bi at discharge, mean 19 (2.6) 18 (3.9)
mRs at discharge, mean 1.0 (1.1) 1.3 (1.2)
MMse, mean 26.5 (3.2) 26.1 (4.0)
Notes: coronary heart disease, previous myocardial infarction or present angina pectoris; hyperlipidemia = total cholesterol >5 mmol/l or lDl >3 mmol/l. *Hypertension, 
use of blood pressure-lowering drugs at baseline, at 12 months: systolic blood pressure >140 mmHg.
Abbreviations: blood pressure, Barthel activities of Daily living index; BMi, body mass index; laci, lacunar circulation infarction; lDl, low-density lipoprotein; MMse, Mini 
Mental State Examination; mRS, modified Rankin scale; NIHSS, National Institute of Health Stroke Scale; OSCP, Oxfordshire Community Stroke Project classification; PACI, 
partial anterior circulation infarction; POci, posterior circulation infarction; Taci, total anterior circulation infarction; Tia, transient ischemic attack. 
with lower mortality. In the multivariable Cox regression 
model, including age, hyperlipidemia, AF, BMI, mRS at 
discharge, and MMSE at discharge, only younger age and 
higher BMI remained independent predictors for long-term 
survival over 7 years (HR 1.08, 95% CI 1.05–1.11, and HR 
0.91, 95% CI 0.85–0.97, respectively). In a multivariable 
Cox regression model, without BMI, only age remained 
independent (HR 1.09, 95% CI 1.06–1.12).
Kaplan–Meier survival curves of calculated BMI groups 
are presented in Figure 3.
At baseline, seven patients had BMI <18.5 kg/m2, 74 
between 18.5 and 24.9 kg/m2, 72 between 25 and 29.9 kg/
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Table 2 cox regression; death in relation to intervention, cardiovascular risk factors, stroke subtypes, and functional and cognitive 
assessment
Patients characteristics Univariate HR 95% CI Multivariate HR 95% CI
age (years) 1.10 1.07–1.13 1.08 1.05–1.11
sex, male 1.11 0.71–1.75   
Hypertension 0.96 0.61–1.52   
coronary heart disease 0.64 0.36–1.12   
smoking, present 0,99 0.59–1.68   
Hypercholesterolemia 0.45 0.29–0.71 0.68 0.41–1.13
Daily alcohol use 0.52 0.20–1.30   
Arial fibrillation 0.62 0.37–0.99 1.57 0.92–2.68
Diabetes 0.88 0.43–1.76   
BMi (kg/m2) 0.87 0.82–0.93 0.91 0.85–0.97
Stroke subype, ref: infarct   
Tia 0.74 0.37–1.49
Hemorrhage 0.91 0.39–2.11




Topography, ref: left   
Right 0.95 0.47–1.92
Back 1.11 0.54–2.26
niHss day 1 1.03 0.97–1.08   
niHss at discharge 0.99 0.91–1.10   
mRs at discharge 1.04 1.04–1.48 1.23 0.98–1.53
MMse at discharge 0.92 0.88–0.96 0.98 0.91–1.05
intervention 0.79 0.50–1.23   
Notes: Univariate and multivariate analyses, intention-to-treat group. Variables with P<0.1 in univariate analysis were included in the multivariate analysis. Hypertension = use 
of blood pressure-lowering drugs at baseline, at 12 months: systolic blood pressure >140 mmHg. coronary heart disease, previous myocardial infarction or present angina 
pectoris; diabetes mellitus, an established diagnosis or Hba1c ≥7.0%; hypercholesterolemia, total cholesterol >5 mmol/l or lDl >3 mmol/l.
Abbreviations: BMI, body mass index; LACI, lacunar circulation infarction; LDL, low-density lipoprotein; mRS, modified Rankin scale; MMSE, Mini Mental State Examination; 
NIHSS, National Institute of Health Stroke Scale; OSCP, Oxfordshire Community Stroke Project classification; PACI, partial anterior circulation infarction; POCI, posterior 
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Although mortality was lower with a maximum difference of 
~20% at 7 years, we found no significant effect on survival 
after 7 years of a multifactorial risk factor program given 
during the first year after first-ever stroke or TIA. Lower 
age and higher BMI were independent predictors for 7 years 
survival in this cohort.
intervention and long-term effect on 
mortality
This is a post hoc analysis and clearly underpowered to 
detect differences in clinical outcomes. Our findings must be 
interpreted with caution, but the trend toward better survival 
in the intervention group is similar to the results of a trial of 
70 patients randomized to lifestyle intervention followed for 
3 years.17 Moreover, a recent systematic review and meta-
analysis indicated that lifestyle intervention following stroke 
is significantly associated with lower blood pressure,18 an 
important contributor to the general decline in stroke mortal-
ity. In our study, significantly more patients in the intervention 
group reached the treatment targets for systolic blood pres-
sure and hyperlipidemia at 12 months. The intervention in this 
study included advice regarding diet and encouragement to 
preform regular moderate physical activity, but no significant 
differences were observed between the groups at 12 months. 
Physical activity is associated with reduced cardiovascular 
mortality,19 but more specific training programs and strict 
dietary advices are probably needed to see any difference, as 
shown in previous studies.20,21 Our study differs from previous 
trials in that the study population was older, we included all 
types of stroke, and the follow-up was longer.
The cardiac model of rehabilitation, with pharmacological 
and lifestyle interventions, has widespread availability, and 
studies show effect regardless of age.22 Small studies have 
indicated that stroke patients can benefit in a similar manner 
as patients with heart diseases, both in the postacute period 
and later in the chronic phase.23–25 A large ongoing trial with 
multidomain approach after stroke or TIA is the intensified 
secondary prevention intending a reduction of recurrent 
events in TIA and minor stroke patients (INSPiRE-TMS),26 
with an estimated completion date of December 2018.
Predictors for long-term survival
Lower age and higher BMI were independent predictors for 
long-term survival in this cohort. Taking BMI out of the 
multivariate Cox regression model, since patients in the inter-
vention group had higher BMI at 12 months, did not change 
these results. There is an increasing evidence suggesting an 
inverse relationship between BMI and total poststroke mor-
tality.27,28 However, there is no prospective data on the effect 
of weight loss as part of secondary prevention on survival 
after stroke in adults.29 The negative association between low 
weight and mortality may have several explanations. Most 
importantly, undernourished patients tend to suffer from more 
stroke complication including infections and gastrointestinal 
bleedings during their hospital stay.30 Furthermore, weight 
loss after stroke may be preceded by poor nutritional status 
in the early phase, especially due to swallowing problems.30,31 
In the general population, low BMI is an independent risk 
factor of total mortality in the elderly,32 and poor outcome 
in underweight patients could be a contributing factor to our 
results. At present, AHA guidelines for secondary preven-
tion after stroke or TIA recommend screening for obesity 
with measurement of BMI, but the usefulness of weight loss 
among patients with a recent TIA or stroke is uncertain.33 
Our findings support these recommendations, in contrast to 
Table 3 causes of death during follow-up
Causes of death Intervention Control
Heart disease 4 6
infectious disease 10 4





Figure 3 Kaplan–Meier survival curves of calculated body mass index groups.
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guidelines from 2006 which recommended weight loss in 
those with BMI >25 kg/m2.
The impact of different risks factors of stroke differ 
according to both age and etiology.34 Looking at the causes 
of death, fewer patients in the intervention group died of vas-
cular disease. However, due to small numbers, these results 
are difficult to interpret. With increasing age conventional 
vascular risk factors lose their predictive value for stroke, as 
functional status and cognition being more important.35 In 
line with this, and with mean age 71.6 years and all stroke 
types included at baseline, our findings seem reasonable.
strengths and limitations
This is a post hoc analysis of a study originally designed and 
powered to test whether a multifactorial vascular risk factor 
intervention could prevent cognitive impairment, underpow-
ered to study survival. Furthermore, the inclusion of both 
TIA, ischemic and hemorrhagic stroke, with possible differ-
ent attributable risks by different cardiovascular risk factors, 
in combination with the limited sample size, makes it difficult 
to find any group differences. Only patients with life expec-
tancy more than 1 year were included in the study, so our 
findings might not be applied to most of the stroke patients. 
In addition, our findings might be biased by comorbidities 
and age-related complications due to high age at baseline 
and long-time follow-up. However, the strength of our trial is 
the randomized controlled design in a representative sample 
of stroke survivors, with long-term follow-up by the same 
team of physicians and study nurse, which may produce data 
of high quality. Long-term follow-up of RCTs after stroke 
is missing, so our study adds important clinical knowledge.
Conclusion
We found no significant effect on survival after 7 years of a 
multifactorial risk factor program given during the first year 
after first-ever stroke or TIA. Higher BMI is an independent 
predictor for long-term survival in this cohort.
Data sharing statement
The data sets are available from the first and corresponding 
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